financetom
Business
financetom
/
Business
/
Hermes sales rise, with U.S. prices rising 5% more than elsewhere
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hermes sales rise, with U.S. prices rising 5% more than elsewhere
Jul 29, 2025 11:34 PM

PARIS (Reuters) -Birkin bag maker Hermes outpaced rivals with a 9% rise in quarterly sales, showing the continued appetite from rich shoppers for its coveted, $10,000 handbags.

The company said it raised prices by 7% globally this year, and by an additional 5% in the United States, where Hermes said it would fully pass on the effects of tariffs to its clients.

Speaking to journalists on a call, Hermes executive chairman Axel Dumas said these price rises would probably suffice to offset the 15% tariff rate agreed between the Trump administration and the EU.

Sales for the second quarter to the end of June reached 3.9 billion euros ($4.50 billion), up 9% at constant rates, Hermes said on Thursday, broadly in line with analyst expectations for a 10% rise, according to a Visible Alpha consensus cited by UBS.

($1 = 0.8657 euros)

(Reporting by Tassilo Hummel, editing by Mimosa Spencer)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
China Vanke's CEO, chairman resign amid growing liquidity worries
China Vanke's CEO, chairman resign amid growing liquidity worries
Jan 27, 2025
(Reuters) - Indebted property developer China Vanke said on Monday its chairman Yu Liang and chief executive Zhu Jiusheng applied to resign from their positions, amid intensifying worries over the company's liquidity as it faces several looming debt maturity deadlines this month. (Reporting by Himanshi Akhand in Bengaluru) ...
Inogen Enters Partnership With Jiangsu Yuyue Medical Equipment
Inogen Enters Partnership With Jiangsu Yuyue Medical Equipment
Jan 27, 2025
03:40 AM EST, 01/27/2025 (MT Newswires) -- Inogen (INGN) said Sunday it has entered into a partnership with Jiangsu Yuyue Medical Equipment & Supply with the intention of boosting its portfolio of respiratory products, expanding its research pipeline and accelerating its entry into China. Under the agreement, a Jiangsu Yuyue affiliate will also invest about $27.2 million in Inogen, representing...
Biogen, Eisai Receive US FDA Biologics Approval for Leqembi Dosing
Biogen, Eisai Receive US FDA Biologics Approval for Leqembi Dosing
Jan 27, 2025
03:58 AM EST, 01/27/2025 (MT Newswires) -- Biogen (BIIB) and Eisai said Sunday that the US Food and Drug Administration has approved the supplemental biologics license application for once-every-four-weeks lecanemab-irmb intravenous maintenance dosing for treating early Alzheimer's disease. The indication for the drug, also known as Leqembi, is for patients with either mild cognitive impairment or mild dementia after 18...
Italy's MPS shares fall ahead of Mediobanca board meeting on bid
Italy's MPS shares fall ahead of Mediobanca board meeting on bid
Jan 27, 2025
ROME/MILAN (Reuters) - Shares in Monte dei Paschi (MPS) fell again on Monday, extending Friday's losses, signalling lingering investor doubts over the bailed out Tuscan bank's bid for bigger rival Mediobanca. On Friday, the state-backed lender launched a surprise 13.3-billion-euro all-share ($13.9 billion) bid for Mediobanca, whose board meets on Tuesday to start reviewing the offer. Based on Italian takeover...
Copyright 2023-2026 - www.financetom.com All Rights Reserved